Skip to content
All Updates
- 23. Recall Alert – Class II – Drug Products – Provincial reportsApril 14, 2026
- 22. Recall Alert – Drug Products declared substandard by Provincial laboratories.April 14, 2026
- 21. Rapid Alert – SPURIOUS Nandrolone Injection 100mg/mlApril 14, 2026
- 20. Rapid Alert – SPURIOUS DYDROGESTERONE TABLETSApril 14, 2026
- 19. Recall Alert – WHO Recall Class-IIApril 14, 2026
- 18. Rapid Alert – Spurious TERBIDERM FORTE TABLET (TERBINAFINE 250 mg) & GLANTRIM OPHTHALMIC SOLUTIONApril 14, 2026
- Requirements for Grant Of Drug Manufacturing License by the Way of Basic & Semi-Basic Manufacturing for Blood/ Plasma EstablishmentsMarch 30, 2026
- Notification (S.R.O. 515(l)/2026)March 30, 2026
- Invitation to bid (For the supply of chemicals, glassware, reference standards/USP standards/CRMs and columns)March 25, 2026
- Decisions of the 123rd meeting of the Medical Devices Board (MDB) held on 25-02-2026 (Manual Applications Part-II)March 25, 2026
- Tender for Provision of Record Management ServicesMarch 25, 2026
- Draft Therapeutic Goods (Import and Export) Rules 2026 (For Comments)March 18, 2026
- 17. Volunatry Recall. Osilex-D (Glitz Pharma)March 11, 2026
- Stakeholders are invited to comment on Draft Post-registration variation guidelines for pharmaceutical and biological products (3rd Edition)March 11, 2026
- 16. Recall Alert (Human) – CDL Karachi declared substandard products.March 11, 2026
- 15. Recall Alert (Veterinary) – DTLs Punjab declared substandard products.March 11, 2026
- 14. Recall Alert (Human) – DTLs Punjab Declared substandard drug products.March 11, 2026
- Minutes of the 121st and 122nd meetings of the Medical Devices Board (MDB)March 11, 2026
- 13. Rapid Alert – SPURIOUS TABLET D-GEST DYDROGESTERONE 10 mg) (BATCH NO. DGH007)March 11, 2026
- 12. Rapid Alert – SPURIOUS CAPSULE GABICA 300 mg (BATCH NO. 518C27)March 11, 2026
- 11. Rapid Alert – SPURIOUS & SUBSTANDARD INJECTION VENOFER 5 mL (Batch No. 4721026AA)March 11, 2026
- 10. Rapid Alert – Spurious Injection RHOPHYLAC 300 µg (Batch # P100707423)March 11, 2026
- 09. Rapid Alert – SPURIOUS CEFIXIME 400mg CAPSULE (Batch # LLM034)March 11, 2026
- 08. Recall Alert (Class-II) – DTLs punjab declared substandard drug products.March 11, 2026
- 07. Recall Alert (Human) – DTLs Punjab declared substandard drug products.March 11, 2026
- 06. Recall Alert (Veterinary) – DTLs punjab declared substandard products.March 11, 2026
- Notification of Fee in respect of Regulatory Functions of DRAPMarch 11, 2026
- 05. Recall Alert (Class-I) – CDL declared substandard – Teczone Forte InjectionFebruary 25, 2026
- Circulars for Submission of Summary of Product Characteristics (SmPC) and Risk Management Plans (RMP)February 24, 2026
- 04. Rapid Alert – “Zetol” Unregistered Antiseptic productFebruary 18, 2026
- Minutes of the 117th, 118th, 119th, and 120th Meetings of the Medical Device Board (MDB)February 16, 2026
- 03. Recall Alert (Class-I) – Veterinary Drug Products reports from DTLs Punjab.February 12, 2026
- 02. Recall Alert (Class-II) – Drug Products tested by DTL PunjabFebruary 12, 2026
- 01. Recall Alert (Class-I) – Drug Products tested by DTL Punjab.February 12, 2026
- Safety Alert of Risk of severe itching after discontinuation of long-term use of Cetirizine and LevocetirizineFebruary 9, 2026
- Minutes of 353rd Meeting of Registration Board (14th – 15th January, 2026)February 6, 2026
- Safety Alert of Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) with SemaglutideFebruary 6, 2026
- Safety Alert of Risk of Circulatory Shock with the Sulfamethoxazole and trimethoprim drug combinationFebruary 6, 2026
- Safety Alert of Potential Risk of Suicidal Thoughts with Finasteride and Dutasteride-containing medicinesFebruary 3, 2026
- Safety Alert of Risk of Intrahepatic Cholestasis of Pregnancy with ThiopurinesFebruary 3, 2026
- Safety Alert of Risk of Idiopathic Intracranial Hypertension with MesalazineJanuary 30, 2026
- Safety Alert of Risk of Sacroiliitis with IsotretinoinJanuary 30, 2026
- Guidance Document for Submission of Applications on Form-5F (CTD) for Registration of Pharmaceutical Drug Products for Human UseJanuary 30, 2026
- 136. Rapid Alert – Spurious Tablet EFASTON – Batch # 51062January 23, 2026
- Training session for medical device stakeholders on the MDMC licensing and product registration portalJanuary 22, 2026
- 134. Recall Alert (Class-II) – CDL declared substandard – Henafim Paediatric SuspensionJanuary 21, 2026
- 135. Rapid Alert – Unregistered OMNIVISC 2% (Substandard & Misbranded)January 21, 2026
- Decisions of the 115th and 116th Meetings of the Medical Device Board (MDB) held on 01 & 07 Jan 2026 (Manual Applications – Part II)January 21, 2026
- Minutes of the 6th Meeting of the Pharmacovigilance Risk Assessment Expert Committee (PRAEC)January 21, 2026
- 133. Recall Alert (Class-I) – Tablet BP-NORM (Substandard & Adulterated)January 21, 2026
